Evidence map›Paper›PMID 38136363›Full record

ReviewCancers2023

Endoscopic Treatment of Malignant Hilar Biliary Obstruction.

Jakub Pietrzak, Adam Przybyłkowski

Registry-linked trialAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07558304 (Randomized Clinical Trial of Suprapapillary Drainage With Metal Stent vs. Routine Internal-External Transpapillary Drainage in Patients With Malignant Hilar Biliary Obstruction), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07558304 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Randomized Clinical Trial of Suprapapillary Drainage With Metal Stent vs. Routine Internal-External Transpapillary Drainage in Patients With Malignant Hilar Biliary Obstruction

TypeinterventionalSponsorHospital de Clinicas de Porto AlegreRan2026 to 2028Enrolled84ConditionsCholangiocarcinoma, Bile Duct Neoplasms, Malignant Biliary ObstructionArmsPercutaneous transpapillary internal-external biliary drainage, Percutaneous suprapapillary biliary drainage with self-expanding metal stent
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Role of Endoscopy in Malignant Biliary Obstruction.Diagnostics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jakub PietrzakDepartment of Gastroenterology and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0009-0009-9824-0427
Adam PrzybyłkowskiDepartment of Gastroenterology and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-5851-2856

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stent implantation is an effective approach for palliative treatment of Bismuth-Corlette type III-IV malignant hilar biliary obstructions (MHBOs). In this article, we reviewed the currently used access methods for biliary stent placement (percutaneous transhepatic biliary drainage, endoscopic biliary drainage, endosonography guided biliary drainage), the available stent types (plastic stent, self-expanding metallic stent, full cover self-expanding metallic stent, radioactive self-expanding metallic stent), major approaches (unilateral, bilateral) and deployment methods (stent-in-stent, stent-by-stent). Finally, this review gives an outlook on perspectives of development in stenting and other palliative methods in MHBO.

Indexed as

cholangiocarcinomaendoscopic biliary drainageendoscopic retrograde cholangiopancreatographymalignant hilar biliary obstruction

Identifiers

PMID38136363
PMCPMC10741735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.